Rollini, Fabiana <br/><br/>
Pharmacodynamic effects of cangrelor on platelet P2Y12 receptor-mediated signaling in prasugrel-treated patients.  [electronic resource] 

 -  JACC. Cardiovascular interventions  Apr 2014 
 - 426-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2013.11.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Monophosphate--analogs & derivatives<br/>Aged<br/>Blood Platelets--drug effects<br/>Cell Adhesion Molecules--blood<br/>Coronary Artery Disease--blood<br/>Drug Administration Schedule<br/>Female<br/>Florida<br/>Humans<br/>Male<br/>Microfilament Proteins--blood<br/>Middle Aged<br/>Percutaneous Coronary Intervention<br/>Phosphoproteins--blood<br/>Phosphorylation<br/>Piperazines--administration & dosage<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Function Tests<br/>Prasugrel Hydrochloride<br/>Prospective Studies<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Receptors, Purinergic P2Y12--blood<br/>Signal Transduction--drug effects<br/>Thiophenes--administration & dosage<br/>Time Factors<br/>Vasodilator-Stimulated Phosphoprotein